IFM Therapeutics LLC, an innate immunity specialist that's quickly sparked major deals with big pharma, is stoking the generative fire at its heart with $55.5 million in new financing led by ...
HOUSTON, Nov. 01, 2019 (GLOBE NEWSWIRE) -- IFM Investors Pty Ltd (“IFM”) and Buckeye Partners, L.P. (“Buckeye”) today announced the completion of the acquisition of Buckeye by entities affiliated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback